Mirbeg 25 Tablet ER
Marketer
Ipca Laboratories Ltd
Salt Composition
Mirabegron (25mg)
Overview Mirbeg 25 Tablet ER
Extended-release Mirbeg 25mg tablets manage overactive bladder symptoms such as frequent urination, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Follow your doctor's prescribed dosage and duration; it may be taken with or without food. Swallow the tablet whole; do not crush or chew. Discontinue use only under medical supervision, as abrupt cessation may worsen symptoms. Complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects promptly. Before starting treatment, disclose all other medications and any existing health conditions, including pregnancy or breastfeeding. Patients with liver or kidney impairment require close monitoring and regular check-ups as directed by their physician.
Primary Ingredients of Mirbeg 25 Tablet ER
No text provided to rephrase.
Uses of Mirbeg 25 Tablet ER
Managing overactive bladder (OAB) symptoms
Major Benefits of Mirbeg 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mirbeg 25 ER tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Mirbeg 25 ER tablets can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Mirbeg 25 Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Mirbeg 25 Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Mirbeg 25 Extended-Release Tablets can be consumed with or without food, although consistent daily timing is recommended.
How Mirbeg 25 Tablet ER works:
Mirbeg 25 Extended-Release tablets utilize a beta-3 adrenergic agonist mechanism. This activates bladder receptors, promoting relaxation of the bladder musculature and thus reducing urinary frequency, urgency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Mirbeg 25 Tablet ER and alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Extended-release Mirbeg 25mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Mirbeg 25mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Mirbeg 25 Extended-Release Tablets.
KidneyCAUTION
Patients with severe renal impairment should exercise caution when using Mirbeg 25 Extended-Release tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Mirbeg 25 Extended-Release tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Mirbeg 25 Extended-Release tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Mirbeg 25 Tablet ER :
Should you forget a Mirbeg 25 Tablet ER dose, take it immediately if you remember. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Mirbeg 25 Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Anilide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
| Action Class | Beta-3 agonist for bladder control |






